Veracyte Q2 Revenue USD 150.3 Million Vs. IBES Estimate USD 144.6 Million
VCYT•Second-quarter results
Jul 30 (Reuters) - Veracyte Q2 net income USD 25.5 million.
- Q2 gross margin 72%
- Q2 adjusted operating expenses USD 70 million
- outlook FY revenue USD 590-596 million vs. IBES estimate USD 586.4 million




